# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Axenfeld-Rieger syndrome
- **MONDO ID:**  (if available)
- **Category:** Genetic

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Axenfeld-Rieger syndrome**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** falcon
**Generated:** 2025-12-15T09:08:48.745203

1. reis2023axenfeldriegersyndromemore pages 1-2
2. michels2023ophthalmologicalmanifestationsof pages 2-4
3. qi2022screeningofpathogenic pages 4-5
4. mitchell2025axenfeldriegersyndromeassociated pages 1-3
5. reis2023axenfeldriegersyndromemore pages 4-4
6. reis2023axenfeldriegersyndromemore pages 1-1
7. https://doi.org/10.1136/jmg-2022-108646
8. https://doi.org/10.2147/opth.s379853,
9. https://doi.org/10.1038/s41467-024-48134-2
10. https://doi.org/10.1101/2025.06.05.25327661,
11. https://doi.org/10.1016/j.ydbio.2010.01.027,
12. https://doi.org/10.1242/dev.126920
13. https://doi.org/10.1093/hmg/ddy074,
14. https://doi.org/10.1167/iovs.13-12447
15. https://doi.org/10.1172/JCI38519
16. https://doi.org/10.1093/hmg/ddaa163
17. https://doi.org/10.3174/ajnr.a7995,
18. https://doi.org/10.1136/jmg-2022-108646.
19. https://doi.org/10.2147/opth.s379853.
20. https://doi.org/10.3174/ajnr.a7995.
21. https://doi.org/10.1101/2025.06.05.25327661.
22. https://doi.org/10.1016/j.ydbio.2010.01.027.
23. https://doi.org/10.1242/dev.126920.
24. https://doi.org/10.1093/hmg/ddy074.
25. https://doi.org/10.1038/s41467-024-48134-2.
26. https://doi.org/10.1093/hmg/ddaa163.
27. https://doi.org/10.1136/jmg-2022-108646,